| the effect of simvastatin on lymphocyte secretory function in patients with impaired fasting glucose. | |
| | |
MedLine Citation:
|
PMID: 21108528 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
No previous study has determined the impact of statins on lymphocyte secretory function in patients with the early stages of glucose metabolism abnormalities. Our study aimed at assessing the strength of a lymphocyte-suppressing effect of simvastatin in patients with impaired fasting glucose with reference to its action in dyslipidemic subjects. Phytohemagglutinin-stimulated lymphocytes of impaired fasting glucose (n = 32) and hypercholesterolemic (n = 30) subjects produced more interleukin-2, interferon-g, and tumor necrosis factor-a than lymphocytes of 31 matched subjects with normal plasma lipids and glucose tolerance. Apart from lowering plasma lipids, in both treatment groups, simvastatin (40 mg daily) reduced lymphocyte cytokine release to the level observed in control subjects, which was accompanied by a decrease in plasma high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 levels. Our study shows that already at the early stages of glucose metabolism abnormalities, lymphocyte secretory function is disturbed to a similar degree as in hypercholesterolemia. Simvastatin is an effective lymphocyte-suppressing and anti-inflammatory agent irrespective of plasma lipid levels. The treatment-induced reduction in lymphocyte cytokine release and systemic inflammation may contribute to the clinical effectiveness of statins in the prevention and therapy of atherosclerosis in subjects with early glucose metabolism abnormalities and dyslipidemia. |
| | |
Authors:
|
Robert Krysiak; Boguslaw Okopien |
Related Documents
:
|
3050268 - The effect of low and high nacl diets on oral glucose tolerance. 9258268 - Decreased glucose effectiveness but not insulin resistance in glucose-tolerant offsprin... 3533668 - Glucose tolerance after portacaval shunt in liver cirrhosis. 7806018 - Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative ... 5108 - Synthesis and properties of carbonylbis(methionyl)insulin, a proinsulin analogue which ... 10022708 - Penile stump advancement as an alternative to perineal urethrostomy after penile amputa... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 56 ISSN: 1533-4023 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 491-7 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland. r.krysiak@interia.pl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A novel class of nitrovasodilators: potency and in vitro tolerance of organic aminoalkylnitrates.
Next Document: Measuring the externality of antibacterial use from promoting antimicrobial resistance.